calcium gluconate has been researched along with Sensation Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, CD | 1 |
| Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB | 1 |
1 trial(s) available for calcium gluconate and Sensation Disorders
| Article | Year |
|---|---|
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2011 |
1 other study(ies) available for calcium gluconate and Sensation Disorders
| Article | Year |
|---|---|
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders | 2014 |